Clinical Outcome and Cost-effectiveness of Routine Follow-up Coronary Angiography after Percutaneous Coronary stenting in Japan

Clinical Outcome and Cost-effectiveness of Routine Follow-up Coronary Angiography after Percutaneous Coronary stenting in Japan - Cost-effectiveness of Routine Follow-up Coronary Angiography after Percutaneous Coronary stenting

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039768

Enrollment

856

Registered

2020-03-12

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing coronary artery stenting

Exclusion criteria

Exclusion criteria: Previous CABG within 1 year before Index PCI, concurrent end-stage renal failure on dialysis or cancer treated with surgery or chemotherapy during enrollment and follow-up.

Design outcomes

Primary

Measure	Time frame
The primary endpoint was the 3-year cumulative incidence of major adverse cardiac events and the cumulative cost based on direct medical costs.	—

Secondary

Measure	Time frame
Secondary endpoints included all-cause death, nonfatal myocardial infarction, urgent revascularization, coronary artery bypass grafting, stroke, hospitalization for heart failure, and any coronary revascularization.	—

Countries

Japan

Contacts

Public ContactTomoyuki Takura

Graduate School of Medicine, The University of Tokyo Department of Healthcare Economics and Health Policy

ttakura@m.u-tokyo.ac.jp03-5800-9523

Outcome results